LncRNA GClnc1 may contribute to the progression of ovarian cancer by regulating p53 signaling pathway
Authors:
Open Access
- 19 October 2020
- journal article
- research article
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 64 (4) , 323-329
Abstract
Ovarian cancer (OC) is one of the most prevalent and deadly types of gynecological malignancy. Since current treatments are not effective against OC, it is imperative to develop novel potential therapeutic targets for managing OC. In this study, we aimed to uncover the underlying molecular mechanism of long non-coding RNA (lncRNA) GClnc1 related to p53 signaling pathway in OC. The expression of lncRNA H19 GClnc1 was markedly higher in OC samples than the related normal tissues. Next, we found that lncRNA GClnc1 inhibited p53. In addition, the lncRNA GClnc1 overexpression promoted the cell proliferation and migration in vitro. Subsequently, p53 silencing obligated the effect of lncRNA GCln1 knock down on cell proliferation and migration. To sum up, LncRNA GClnc1 contributes to the progression of OC by regulating p53 signaling pathway. Meanwhile, our findings also suggested that lncRNA GClnc1 may serve as a novel therapeutic target for OC patients.Keywords
This publication has 16 references indexed in Scilit:
- Mutant p53 as a guardian of the cancer cellCell Death & Differentiation, 2018
- Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signalingBiochemical and Biophysical Research Communications, 2018
- Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer2016
- LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification PatternCancer Discovery, 2016
- In vitro-assessment of putative antiprogestin activities of phytochemicals and synthetic UV absorbers in human endometrial Ishikawa cellsGynecological Endocrinology, 2015
- The identification of the biological characteristics of human ovarian cancer stem cells.2014
- miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancerOncology Reports, 2013
- Long non-coding RNAs function annotation: a global prediction method based on bi-colored networksNucleic Acids Research, 2012
- Early versus delayed treatment of relapsed ovarian cancerThe Lancet, 2011
- Evolution and Functions of Long Noncoding RNAsCell, 2009